GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
GLIS1 干预通过靶向 SGK1-STAT3-PD1 通路增强抗 PD-1 疗法治疗肝细胞癌的效果。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-005126
Rong, Dawei; Wang, Yuliang; Liu, Li; Cao, Hengsong; Huang, Tian; Liu, Hanyuan; Hao, Xiaopei; Sun, Guangshun; Sun, Guoqiang; Zheng, Zhiying; Kang, Junwei; Xia, Yongxiang; Chen, Ziyi; Tang, Weiwei; Wang, Xuehao
SGK1
肿瘤
LIS1
肿瘤免疫
JAK/STAT
信号转导
STAT3
细胞生物学
PD-1